Eileen Blasi
Impact in
-
- Hormonal Regulation and Hypertension
- Nephrology top 10%
Papers in
- Oncology 7
- Chemokine receptors and signaling 3
- Peptidase Inhibition and Analysis 2
-
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Ellen Garwitz McMahon (2 shared papers)Amy E. Rudolph (2 shared papers)Ricardo Rocha (1 shared paper)Eric A.G. Blomme (1 shared paper)Jonathan R. R. Heyen (6 shared papers)Aileen D. McHarg (5 shared papers)CAROLYN A. ECELBARGER (3 shared papers)Swasti Tiwari (2 shared papers)
- Journals
- PPAR Research (1 paper)Cancer Research (1 paper)Pharmacological Research (1 paper)Journal of Cardiac Failure (1 paper)Nucleic Acid Therapeutics (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Eileen Blasi
16 papers receiving 807 citations
Peers
Comparison fields: 5 of 75
- Endocrinology, Diabetes and Metabolism 361
- Nephrology 64
- Cardiology and Cardiovascular Medicine 168
- Surgery 184
- Nutrition and Dietetics 65
Countries citing papers authored by Eileen Blasi
This map shows the geographic impact of Eileen Blasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Blasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Blasi more than expected).
Fields of papers citing papers by Eileen Blasi
This network shows the impact of papers produced by Eileen Blasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Blasi. The network helps show where Eileen Blasi may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Blasi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 454 | |
| 2 | 2002 | 90 | |
| 3 | 2013 | 64 | |
| 4 | 2017 | 44 | |
| 5 | 2008 | 31 | |
| 6 | 2009 | 29 | |
| 7 | 2009 | 23 | |
| 8 | 2010 | 22 | |
| 9 | 2009 | 19 | |
| 10 | 2019 | 19 | |
| 11 | 2021 | 16 | |
| 12 | 2014 | 8 | |
| 13 | PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 | 2007 | 7 |
| 14 | 2025 | 3 | |
| 15 | 2007 | 1 | |
| 16 | 2008 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2026 | 0 |
About Eileen Blasi
Eileen Blasi is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Hematology, Immunology and Molecular Biology, having authored 19 papers that have together received 831 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (3 papers), Cardiovascular Function and Risk Factors (2 papers), Hormonal Regulation and Hypertension (2 papers), Peptidase Inhibition and Analysis (2 papers), Multiple Myeloma Research and Treatments (2 papers), Adipose Tissue and Metabolism (2 papers), Immunotherapy and Immune Responses (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (361 citations), Nephrology (64 citations), Cardiology and Cardiovascular Medicine (168 citations), Surgery (184 citations) and Nutrition and Dietetics (65 citations). Eileen Blasi has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Ellen Garwitz McMahon, Amy E. Rudolph, Ricardo Rocha, Eric A.G. Blomme, Jonathan R. R. Heyen, Aileen D. McHarg, CAROLYN A. ECELBARGER, Swasti Tiwari, John F. Van Vleet and Gregory E. Frierdich. Their work appears in journals such as PPAR Research, Cancer Research, Pharmacological Research, Journal of Cardiac Failure and Nucleic Acid Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.